Press Releases :: BiomX, Inc. (PHGE)

Aug 27, 2019 7:30am EDT

BiomX Announces In-house Phage Manufacturing Facility

Jun 11, 2019 2:00am EDT

BiomX Licenses Novel Targets for Liver Disease Phage Therapy Program From JSR Corporation in Japan

Feb 20, 2019 7:30am EST

BiomX Raises $32 Million in Series B Financing

Dec 12, 2018 7:30am EST

BiomX Enters Collaboration with Johnson & Johnson Innovation for Discovery of Microbiome-based Biomarkers for IBD

Dec 11, 2018 7:30am EST

BiomX Appoints Sailaja Puttagunta as Chief Medical Officer

Jan 30, 2018 7:30am EST

BiomX Licenses Novel Bacterial Targets for the Treatment of Inflammatory Bowel Disease

Dec 19, 2017 7:30am EST

BiomX Acquires RondinX to Boost Microbiome Discovery and Development Capabilities

May 15, 2017 7:30am EDT

BiomX Raises $24 Million in Series A Funding to Develop Microbiome Therapeutics

Previous
1…
4
5
6
7
8
9
10
11
12
13

Investor Contact Information

Company

BiomX, Inc.
708 Quince Orchard Rd
Suite 205
Gaithersburg, MD 20878
USA
info@biomx.com

Investor Relations

Ben Cohen
benc@biomx.com